Market Place
Sourcing Support
Pfizer`s Biologics Ngenla Receive Suppl Approval in US
10 Jul 2025 //
FDA
Pfizer`s Biologics Elrexfio Receive Suppl Approval in US
08 Jul 2025 //
FDA
Pfizer Inc`s Tivdak Receives Approval in Europe
28 Mar 2025 //
EMA
Pfizer`s Biologic Elelyso Receives Suppl Approval in US
17 Jan 2025 //
FDA
Pfizer`s Biologic Hympavzi (Marstacimab-hncq) Receives Approval in US
11 Oct 2024 //
FDA
Pfizer`s Biologic Zirabev (Bevacizumab) Receives Suppl Approvals in US
28 Aug 2024 //
FDA
Pfizer Europe Emblaveo (aztreonam / avibactam) Receives Approval in Europe
24 Apr 2024 //
EMA
Pfizer`s Velsipity (etrasimod) Receives Approval in Europe
16 Feb 2024 //
EMA
Pfizer`s Biologic IIxifi (Infliximab) Receives Approval in the U.S.
26 Dec 2023 //
FDA
Pfizer`s Ruxience (rituximab) Receives Approval in Europe
15 Dec 2023 //
EMA
Pfizer Inc`s Biologic Ruxience (Rituximab) Receives Approval in the U.S.
16 Oct 2023 //
FDA
Pfizer`s Biologic Abrilada (adalimumab) Receives Approval in the U.S.
04 Oct 2023 //
FDA
Pfizer`s Biologic Abrilada (adalimumab) Receives Approval in the U.S.
16 Aug 2023 //
FDA
Pfizer`s Biologic Elrexfio (elranatamab) Receives Approval in the U.S.
14 Aug 2023 //
FDA
Pfizer`s Paxlovid (nirmatrelvir, ritonavir) Approved In Europe
27 Jun 2023 //
EMA
Pfizer`s Biologic Abrilada (Adalimumab) Receives Approval in the U.S.
14 Jun 2023 //
FDA
Pfizer`s Oxbryta (Voxelotor) Approved In Europe
06 Jun 2023 //
EMA
Pfizer`s Biologic Elelyso (Taliglucerase Alfa) Receives Approval in the U.S.
09 May 2023 //
FDA
Pfizer Europe`s Paxlovid (nirmatrelvir) Receives Approval in the Europe
23 Nov 2022 //
EMA
Pfizer`s Biologic Elelyso (Taliglucerase Alfa) Receives Approval in the U.S.
30 Aug 2022 //
FDA
Pfizer Abrilada (adalimumab-afzb) Receives BLA Approval Approval in the U.S.
30 Jul 2022 //
FDA
Pfizer Europe Apexxnar Receives Approval in Europe
11 May 2022 //
EMA
Pfizer Europe`s Biologic Ngenla (Somatrogon) Receives Approval in Europe
21 Mar 2022 //
EMA
Amneal Pharm`s Generic Lacosamide Receives Approval in the U.S.
17 Mar 2022 //
FDA
Pfizer Inc`s Biologic Ngenla (Somatrogon) Receives Approval in Europe
02 Mar 2022 //
EMA
Pfizer`s Biologic Ngenla (Somatrogon) Receives Approval in Europe
02 Mar 2022 //
EMA
Pfizer`s Biologic Apexxnar (P. Polysaccharide) Receives Approval in Europe
02 Mar 2022 //
EMA
Pfizer`s Paxlovid (ritonavir) Receives Approval in Europe.
28 Jan 2022 //
EMA
Pfizer`s Cibinqo (Abrocitinib) Receives Approval in Europe
09 Dec 2021 //
EMA
Pharmacia`s Biological Pegvisomant Receives Supplemental Approval In the US
20 Aug 2021 //
FDA
Pfizer`s Elelyso (Taliglucerase Alfa) Receives Supplemental Approval In U.S
06 Nov 2020 //
FDA
Pfizer Europe`s Generic Daurismo (Glasdegib) Receives Approval in Europe
10 Jul 2020 //
EMA
Pfizer`s Trazimera (Trastuzumab -Qyyp) Receives Supplemental Approval In U.S
13 May 2020 //
FDA
Pfizer Europe Generic Staquis(Crisaborole) Receives Approval In Europe
22 Apr 2020 //
EMA
Pfizer`s IXIFI (infliximab-qbtx) Receives Supplimental Approval in U.S
14 Jan 2020 //
FDA
Pfizer Inc.`s ZIRABEV (BEVACIZUMAB-BVZR) Receives Approval In US
27 Jun 2019 //
FDA
EMA Approves Cisplatin; List of nationally authorised medicinal products
05 Nov 2018 //
EMA
Pfizer`s Biological Trazimera (trastuzumab) Receives Approval in Europe
20 Oct 2018 //
EMA
Pfizer`s Dynastat (parecoxib sodium) Receives Approval in Europe
12 Oct 2018 //
EMA
Pfizer`s Nimenrix Biological Receives Approval in Europe
12 Oct 2018 //
EMA
Pfizer`s Biological Trazimera (trastuzumab) Receives Approval in Europe
17 Aug 2018 //
EMA
Pfizer’s Ixifi (Infliximab-Qbtx ) Receives Supplemental Approval In US
18 Dec 2017 //
FDA
Pfizer`s Besponsa (inotuzumab ozogamicin) Receives Approval In Europe
13 Jul 2017 //
EMA
Pfizer’s Trumenba Receives Approval In Europe
06 Jun 2017 //
EMA
Pfizer’s Xeljanz Tofacitinib Receives Approval In Europe
31 Mar 2017 //
EMA
Pfizer Limited Gets EU Nod For Lifmior (etanercept)
13 Mar 2017 //
EMA
Pfizer Gets EU Nod For Ibrance
25 Nov 2016 //
EMA
Anvisa approves novel medicines for kidney cancer and lung disease
16 Dec 2015 //
ANVISA
Wyeth`s Rapamune (sirolimus) Approved in USA For LAM
29 May 2015 //
FDA
Arena Pharmaceuticals BELVIQ (Lorcaserin HCl) Approved in South Korea for Weight Management
03 Feb 2015 //
PRESS RELEASE
